AVENTIS PHARMA LIMITED
Patent Applications and Registrations
Patent applications and USPTO patent grants for AVENTIS PHARMA LIMITED.The latest application filed is for "slave wheel counter mechanism useable with an inhaler".
Company Profile
0.35.17
- AVENTIS PHARMA LIMITED - West Malling Kent GB
- Aventis Pharma Limited - West Maling GB
- AVENTIS PHARMA LTD - West Malling GB
- Aventis Pharma Limited - Kent GB
- Aventis Pharma Ltd. - Tokyo JP
- Aventis Pharma Ltd. - Kent GB
- Aventis Pharma Limited - West Malling Kent GB
Patent Activity
| Patent | Date |
|---|---|
| Inhaler device and method of administering a medicament Grant 9,295,793 - Ferris , et al. March 29, 2 | 2016-03-29 |
| Compounds as PDE IV and TNF inhibitors Grant 8,129,537 - Fenton , et al. March 6, 2 | 2012-03-06 |
| Slave wheel counter mechanism useable with an inhaler Grant 8,083,127 - Minshull , et al. December 27, 2 | 2011-12-27 |
| Slave Wheel Counter Mechanism Useable With An Inhaler App 20110067695 - Minshull; Stephen John ; et al. | 2011-03-24 |
| Mechanical doses counter for a powder inhaler Grant 7,827,989 - Butterworth , et al. November 9, 2 | 2010-11-09 |
| Compounds as PDE IV and TNF Inhibitors App 20100240677 - FENTON; Garry ; et al. | 2010-09-23 |
| Slave wheel counter mechanism useable with an inhaler Grant 7,726,555 - Minshull , et al. June 1, 2 | 2010-06-01 |
| Compounds as PDE IV and TNF inhibitors Grant 7,652,144 - Fenton , et al. January 26, 2 | 2010-01-26 |
| Improvements In Or Relating To Inhalers App 20090114219 - Ferris; Christopher ; et al. | 2009-05-07 |
| Heteroaryl-cyclic acetals Grant 7,479,501 - Collis , et al. January 20, 2 | 2009-01-20 |
| Mechanical Doses Counter for a Powder Inhaler App 20080210226 - BUTTERWORTH; Noel ; et al. | 2008-09-04 |
| Compounds as PDE IV and TNF Inhibitors App 20080132706 - FENTON; Garry ; et al. | 2008-06-05 |
| Slave Wheel Counter Mechanism Useable With An Inhaler App 20080066750 - Minshull; Stephen John ; et al. | 2008-03-20 |
| Substituted azabicyclic compounds Grant 7,329,675 - Cox , et al. February 12, 2 | 2008-02-12 |
| Inhaler Grant 7,322,352 - Minshull , et al. January 29, 2 | 2008-01-29 |
| Azaindoles Grant 7,227,020 - Cox , et al. June 5, 2 | 2007-06-05 |
| Substituted tetrahydroisoquinolines Grant 7,211,586 - Fenton , et al. May 1, 2 | 2007-05-01 |
| Substituted alkanoic acids Grant 7,166,616 - Harris , et al. January 23, 2 | 2007-01-23 |
| Method and packaging for pressurized containers App 20060144735 - Baker; Frank C. | 2006-07-06 |
| Stable pharmaceutical products App 20060104917 - Wayland; Ruth | 2006-05-18 |
| Compounds as PDE IV and TNF-inhibitors Grant 7,045,660 - Fenton , et al. May 16, 2 | 2006-05-16 |
| Milling process for the production of finely milled medicinal substances Grant 7,041,318 - Authelin , et al. May 9, 2 | 2006-05-09 |
| Compounds as PDE IV and TNF-inhibitors App 20060084809 - Fenton; Garry ; et al. | 2006-04-20 |
| Method and packaging for pressurized containers Grant 7,025,205 - Barker April 11, 2 | 2006-04-11 |
| Inhaler Grant D516,211 - Minshull , et al. February 28, 2 | 2006-02-28 |
| Human antithrombin variants Grant 7,001,993 - Koide February 21, 2 | 2006-02-21 |
| Imidazolyl-cyclic acetals Grant 6,989,395 - Bamborough , et al. January 24, 2 | 2006-01-24 |
| Milling process for the production of finely milled medicinal substances App 20060002864 - Authelin; Jean-Rene ; et al. | 2006-01-05 |
| Pressurized aerosol dispenser Grant 6,971,556 - Shadwell , et al. December 6, 2 | 2005-12-06 |
| Process for producing fine medicinal substance App 20050214228 - Begon, Dominique ; et al. | 2005-09-29 |
| Inhaler Grant D509,296 - Minshull , et al. September 6, 2 | 2005-09-06 |
| Substituted azabicyclic compounds App 20050038069 - Cox, Paul Joseph ; et al. | 2005-02-17 |
| Inhaler App 20040211420 - Minshull, Stephen John ; et al. | 2004-10-28 |
| Azaindoles App 20040198737 - Cox, Paul J. ; et al. | 2004-10-07 |
| Substituted azabicyclic compounds Grant 6,800,645 - Cox , et al. October 5, 2 | 2004-10-05 |
| Compounds as PDE IV and TNF-inhibitors App 20040171618 - Fenton, Garry ; et al. | 2004-09-02 |
| Azaindoles Grant 6,770,643 - Cox , et al. August 3, 2 | 2004-08-03 |
| Indane derivatives Grant 6,762,199 - Fenton , et al. July 13, 2 | 2004-07-13 |
| Substituted tetrahydroisoquinolines App 20040122047 - Fenton, Garry ; et al. | 2004-06-24 |
| Substituted bicyclic heteroaryl compounds and their use as integrin antagonists Grant 6,706,738 - Clark , et al. March 16, 2 | 2004-03-16 |
| Imidazolyl-cyclic acetals App 20040038991 - Bamborough, Paul L. ; et al. | 2004-02-26 |
| Milling process for the production of finely milled medicinal substances Grant 6,641,063 - Vemuri , et al. November 4, 2 | 2003-11-04 |
| Dihydro-benzo(1,4)oxazines Grant 6,632,814 - Bourzat , et al. October 14, 2 | 2003-10-14 |
| Substituted ureas Grant 6,620,832 - Eastwood September 16, 2 | 2003-09-16 |
| Aza-bicycles which modulate the inhibition of cell adhesion Grant 6,608,084 - Bourzat , et al. August 19, 2 | 2003-08-19 |
| Imidazolyl-cyclic acetals Grant 6,602,877 - Bamborough , et al. August 5, 2 | 2003-08-05 |
| Inhalation device Grant 6,557,550 - Clarke May 6, 2 | 2003-05-06 |
| Substituted anilides Grant 6,479,519 - Astles , et al. November 12, 2 | 2002-11-12 |
| Capsule opening arrangement for use in a powder inhaler Grant 6,470,884 - Horlin October 29, 2 | 2002-10-29 |
| Substituted .beta.-alanines Grant 6,352,977 - Astles , et al. March 5, 2 | 2002-03-05 |
| Abuse resistant tablets Grant 6,309,668 - Bastin , et al. October 30, 2 | 2001-10-30 |
| Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group Grant 6,255,326 - Ashton , et al. July 3, 2 | 2001-07-03 |
Company Registrations
| NCAGE Code | K4587 | AVENTIS PHARMA LTD |
| NCAGE Code | E0496 | AVENTIS PHARMA LTD |
| CAGE Code | E0496 | AVENTIS PHARMA LTD |
| CAGE Code | K4587 | AVENTIS PHARMA LTD |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 